Interview with Ted Miller, communications director for NARAL ProChoice America, conducted by Between the Lines' Melinda Tuhus
FDA Approves Over-the-Counter Sale of Morning-After Pill Decision excludes women under 18
Interview with Ted Miller, communications director for NARAL ProChoice America, conducted by Melinda Tuhus
On Aug. 24, the Food and Drug Administration approved the over-the-counter sale of the morning-after pill, known as Plan B, to women over 18. This decision was the culmination of a five-year battle to increase access to the drug, which can prevent pregnancy if taken within 72 hours of unprotected intercourse. The sooner it's taken, the more effective it is.
The government's decision means that women under 18 will not be able to purchase Plan B without a prescription, despite the recommendation of two FDA advisory panels that it is safe for all ages.
The fight began in February 2001 when more than 60 medical and consumer groups filed a "citizen's petition" with the FDA to make emergency contraception available over the counter, asserting that the morning-after pill was safe enough to be sold without a doctor's supervision. Religious right and anti-abortion activists have opposed Plan B, calling it an abortefacient, but scientific opinion generally holds that it prevents conception and is thus a method of birth control, not abortion.
Between the Lines' Melinda Tuhus spoke with Ted Miller, communications director for NARAL Pro Choice America, about his group's three-year effort to win FDA approval for over-the-counter access to Plan B. He discusses what the compromise decision means for women's health, and how anti-choice groups are likely to react.
For more information on the fight for access to Plan B, call NARAL at (202) 973-3000 or visit the group's website at www.prochoiceamerica.org
LISTEN to this week's half-hour program of Between The Lines by clicking on one of the links below:
http://www.btlonline.org
*
"Between The Lines" is a half-hour syndicated radio news magazine that each week features a summary of under-reported news stories & interviews with activists & journalists who offer progressive perspectives on international, national & regional political, economic & social issues. Because "Between The Lines" is independent of all publications, media networks or political parties, we are able to bring a diversity of voices to the airwaves generally ignored or marginalized by the major media. For more information on this week's topics & to check out our text archive listing topics & guests presented in previous programs visit: http://www.btlonline.org
*
"Between the Lines," WPKN 89.5 FM's weekly radio news magazine can be heard Tuesdays at 5:30 p.m. ET; Wednesdays at 8 a.m. ET & Saturdays at 2 p.m. ET (Wednesday's show airs at 7:30 a.m. ET during fundraising months of April & October).
*
For an email subscription of "Between The Lines Weekly Summary" which features a RealAudio link to the week's program for Between The Lines, send an email to btlsummary-subscribe@lists.riseup.net
*
For an email subscription of "Between The Lines Q&A" which features a RealAudio link & weekly transcript to one of the interviews featured on Between The Lines, send an email to btlqa-subscribe@lists.riseup.net
*
www.btlonline.org
*
betweenthelines@snet.net
*
www.squeakywheel.net
*
Distributed by Squeaky Wheel Productions
©2006 Between The Lines. All Rights Reserved.
BETWEEN THE LINES c/o WPKN Radio 89.5 FM Bridgeport, Conn...
Original: BTL:FDA Approves OTC Sale of Morning-After Pill Decision excludes women under18